Another mechanism by which RT-induced VEGF-A secretion can enhance a pro-tumor environment is through its influence on endothelial cells by inducing expression of CD95L (or FasL), the ligand for FAS (87, 88). The gene discussed is VEGFA; the disease is neoplasm.